Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Lite Strategy, Inc.: Board approved Series A Certificate of Designation setting forth rights, powers, and preferences of Series A Preferred Shares (effective 2023-10-01).
- Change
- charter amendment
- Effective
- 2023-10-01
Exact text from the filing
on October 1, 2023, the Board approved the Series A Certificate of Designation. The Series A Certificate of Designation sets forth the rights, powers, and preferences of the Series A Preferred Shares.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Lite Strategy, Inc. entered into Rights Agreement with Computershare, Inc. (effective 2023-10-01).
- Action
- entry
- Counterparty
- Computershare, Inc.
- Effective
- 2023-10-01
Exact text from the filing
On October 1, 2023, the Board of Directors (the “Board”) of MEI Pharma, Inc., a Delaware corporation (the “Company”), approved and adopted a Rights Agreement, dated as of October 1, 2023 (the “Rights Agreement”), by and between the Company and Computershare, Inc., as Rights Agent (the “Rights Agent”).
View on SEC.gov